GE HealthCare Technologies Dividenden en inkoop

Dividend criteriumcontroles 0/6

GE HealthCare Technologies is een dividendbetalend bedrijf met een huidig rendement van 0.14%. Volgende betalingsdatum is op 15th November, 2024 met een ex-dividenddatum van 18th October, 2024.

Belangrijke informatie

0.1%

Dividendrendement

0.1%

Terugkoop Rendement

Totaal aandeelhoudersrendement	0.3%
Toekomstig dividendrendement	0.2%
Dividendgroei	-11.8%
Volgende betaaldatum dividend	15 Nov 24
Ex-dividenddatum	18 Oct 24
Dividend per aandeel	US$0.120
Uitbetalingsratio	3%

Recente updates van dividend en inkoop

Recent updates

From Spin-Off To Standout: GE HealthCare Is Pretty Impressive

Oct 30

GE HealthCare: The Image Of More Upside Is Very Real

Sep 18

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

Sep 05

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies' Roar Higher Isn't Over Yet

Mar 09

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Feb 14

GE HealthCare Q4 Earnings: Growth Lagging The Market

Feb 06

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: GEHC betaalt geen noemenswaardig dividend uit voor de US markt. Daarom is het niet nodig om te controleren of de betalingen stabiel zijn.

Groeiend dividend: GEHC betaalt geen noemenswaardig dividend uit voor de US markt. Daarom is het niet nodig om te controleren of de betalingen toenemen.

Dividendrendement versus markt

GE HealthCare Technologies Dividendrendement versus markt

Hoe verhoudt GEHC dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (GEHC)	0.1%
Markt onderkant 25% (US)	1.4%
Markt Top 25% (US)	4.4%
Gemiddelde industrie (Medical Equipment)	1.7%
Analist prognose (GEHC) (tot 3 jaar)	0.2%

Opmerkelijk dividend: Het dividend van GEHC ( 0.14% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de US markt ( 1.35% ).

Hoog dividend: Het dividend GEHC ( 0.14% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.36% ).

Winstuitkering aan aandeelhouders

Verdiendekking: GEHC betaalt geen noemenswaardig dividend uit voor de US markt.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: GEHC betaalt geen noemenswaardig dividend uit voor de US markt.

GE HealthCare Technologies Dividenden en inkoop

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente updates van dividend en inkoop

Upcoming dividend of US$0.03 per share

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

Upcoming dividend of US$0.03 per share

Recent updates

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies Inc. Updates Earnings Guidance for the Full Year 2024

Third quarter 2024 earnings: EPS exceeds analyst expectations

From Spin-Off To Standout: GE HealthCare Is Pretty Impressive

GE HealthCare Technologies Inc. Announces Hospital Pulse, the Newest Tile for Its Command Center Software Platform

GE HealthCare Introduces Easy-To-Use, Easy-To-Learn, Easy-To-Appoint Versana Premier Multi-Purpose Ultrasound System

Upcoming dividend of US$0.03 per share

GE Healthcare Accelerates Artificial Intelligence Adoption with New Offering to Advance Enterprise Imaging

GE HealthCare Technologies Inc. to Report Q3, 2024 Results on Oct 30, 2024

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease

Second quarter dividend of US$0.03 announced

GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint

GE HealthCare: The Image Of More Upside Is Very Real

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024

GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia

Insider recently sold US$1.6m worth of stock

GE HealthCare Q2 Earnings Recap (Rating Downgrade)

Second quarter 2024 earnings: EPS exceeds analyst expectations

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q2, 2024 Results on Jul 31, 2024

GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities

First quarter dividend of US$0.03 announced

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

GE Healthcare Names Adam Holton as Chief People Officer

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

President & CEO of Imaging notifies of intention to sell stock

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Price target increased by 7.6% to US$90.21

Full year 2023 earnings: EPS misses analyst expectations

Now 33% overvalued after recent price rise

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year of 2024

GE HealthCare Q4 Earnings: Growth Lagging The Market

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend